Request Legal Help Now - Free

Advertisement
LAWSUITS NEWS & LEGAL INFORMATION

Liver Damage Warning Issued For Multaq

. By
Washington, DCFederal health officials have issued a warning to doctors and patients regarding the potential for liver damage associated with a recently launched drug for atrial fibrillation.

According to a report by the Associated Press the Food and Drug Administration said it has received reports of liver damage in patients taking Multaq (dronedarone) tablets, including two cases in which patients had to have their livers removed.

Multaq, approved by the FDA in July 2009, is marketed by Sanofi-Aventis SA. The drug is used to treat atrial flutter and atrail fibrillation, which are irregular heart rhythms that can result in stroke. Multaq carries a black box warning stating that it can cause severe adverse reactions and death in people with recent severe heart failure.

READ ABOUT THIS LAWSUIT

Legal Help

If you or a loved one has suffered illness or an adverse health event resulting from the use of the product, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.

ADD YOUR COMMENT ON THIS STORY

Please read our comment guidelines before posting.


Note: Your name will be published with your comment.


Your email will only be used if a response is needed.

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.


Click to learn more about LawyersandSettlements.com

Request Legal Help Now! - Free